WG
QTTB icon

Winton Group’s Q32 Bio QTTB Stock Holding History

Winton Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,275
Closed -$246K – 1542
2020
Q3 		$246K Sell
1,275
-153
-11% -$34.3K 0.01% 1302
2020
Q2 		$390K Buy
1,428
+376
+36% +$100K 0.01% 1235
2020
Q1 		$294K Sell
1,052
-910
-46% -$279K 0.01% 1174
2019
Q4 		$731K Buy
+1,962
New +$562K 0.01% 1139

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winton Group's QTTB Position: Q4 2020 in Review

Winton Group sold out of Q32 Bio (QTTB) in Q4 2020, closing a stake of 1,275 shares — an estimated $246K sold.

Winton Group first reported a position in QTTB in Q4 2019 and held it in 4 quarters. The position peaked at $731K in Q4 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

  • Winton Group reported no remaining Q32 Bio position as of Q4 2020 after selling out during the quarter.
  • Winton Group sold 1,275 Q32 Bio shares in Q4 2020, an estimated $246K.
  • Winton Group first reported a position in Q32 Bio in Q4 2019 and held it in 4 quarters.
  • Winton Group's Q32 Bio position peaked at $731K in Q4 2019.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.